For tofersen, an antisense oligonucleotide that reduces toxic SOD1 protein levels in ALS associated with SOD1 mutation [78], CBIT2 may act synergistically by facilitating the refolding and clearance of misfolded proteins. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.